U.S. biotech company to lay off nearly one third of American staff


  • World
  • Thursday, 20 Jul 2023

SAN FRANCISCO, July 19 (Xinhua) -- U.S. biotech company FibroGen will lay off 104 workers, nearly a third of its U.S. employees, the company announced on Wednesday.

FibroGen, which is based in San Francisco, California, said it would reduce about 32 percent of its U.S. workforce and save 30 million to 35 million U.S. dollars in annual expenses in the future.

The company expects 13 million to 15 million dollars in charges related to the layoffs, including severance pay and employee benefits, according to a corporate filing.

FibroGen shares plunged by more than 85 percent in the past month and were down about 7 percent on Wednesday. The company's market capitalization is now 232 million dollars.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Serbian protesters clash with police over train station disaster
Fake bomb threats linked to Russia briefly close Georgia polling locations
Man arrested at US Capitol with torch, flare gun, Capitol police say
Roundup: T�rkiye expects record e-commerce sales from upcoming shopping spree
Chinese training program helps Tanzania's Zanzibar improve pediatric treatment
Cholera cases in Sudan rise to 30,880, dengue fever to 6,011: health ministry
Over 300 Ghanaian students awarded Chinese Ambassador Scholarships
UAE targets 600 bln USD in foreign investment by 2031 under new strategy
(CIIE) Economic Watch: China shines on opening up, as world openness level degrades
China-Africa-UNIDO Center of Excellence opens in Ethiopia to advance Africa's development

Others Also Read